Equity Profile

IRTC

iRhythm Holdings, Inc.

Health CareHealth Care Equipment$3.7B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions, particularly in cardiac monitoring....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of a company's profitability and financial health, which investors closely monitor.

Expected to be around -$0.35.

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share, which is vital for long-term success.

Not available.

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions, particularly in cardiac monitoring. With a market cap of $4 billion, it plays a crucial role in providing innovative tools for diagnosing heart conditions, which is increasingly important as healthcare moves towards more personalized and technology-driven solutions.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In Q1 2026, iRhythm reported an EPS of -$0.35, which was better than the expected -$0.56, resulting in a positive stock reaction of 6.96% the following day. The company continues to show resilience despite ongoing challenges in the healthcare sector.

Management Promises & Guidance

Focus on increasing customer adoption of their cardiac monitoring solutions.
Commitment to enhancing product offerings through technological advancements.
Plans to improve operational efficiency to drive down costs.

Expectations

Wall Street Expectations

Overall, expectations for iRhythm's upcoming earnings are cautious, given the mixed results in previous quarters. Investors are particularly interested in whether the company can maintain its trend of beating EPS estimates.

Bull Case

If iRhythm can demonstrate strong revenue growth and continued improvement in EPS, it may signal a recovery and increased investor confidence in the company's future.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of stagnation in customer adoption, it could lead to a negative reaction from the market.

Key Metrics to Watch

EPS (Earnings Per Share)

Expected to be around -$0.35.

EPS is a key indicator of a company's profitability and financial health, which investors closely monitor.

Revenue Growth

Not available.

Revenue growth reflects the company's ability to expand its business and capture market share, which is vital for long-term success.

Customer Adoption Rate

Not available.

Understanding how many healthcare providers are adopting iRhythm's solutions can indicate future revenue potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current customer adoption rate for iRhythm's cardiac monitoring solutions?

This metric will be crucial in assessing the company's growth potential and market acceptance of its products.

How does management plan to address operational efficiencies moving forward?

Insights into cost management strategies will help investors understand the company's path to profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for iRhythm's customer adoption rates to accelerate, especially given recent trends in telehealth and remote monitoring.

Supporting Evidence

The company has consistently beaten EPS estimates in recent quarters, indicating stronger-than-expected performance.

Options pricing suggests a higher expected move than historical averages, indicating market anticipation of significant news.

Management's commitment to improving operational efficiency could lead to better-than-expected margins.

Key Risk

If customer adoption rates exceed expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether iRhythm can sustain its recent positive momentum or if it will face ongoing challenges.

Bull Confirmed If

Demonstrating an EPS of -$0.30 or better would confirm the bull case.

Bear Confirmed If

An EPS worse than -$0.50 would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a potential move of about 3.3%, indicating that investors expect some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests a potential stock increase of around 1.17%, confirming a positive outlook.

In-Line / Cautious

A cautious in-line result may lead to muted reactions, reflecting uncertainty in future growth.

Miss

If the company misses expectations, history suggests a minimal reaction, but any significant miss could lead to a downward movement.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on customer adoption rates for cardiac monitoring solutions.
2Details on operational efficiency improvements and cost management strategies.
3Any commentary on competitive landscape and market positioning.
4Insights into product development and technological advancements.
5Management's outlook on future revenue growth and market trends.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions, particularly in cardiac monitoring....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of a company's profitability and financial health, which investors closely monitor.

Expected to be around -$0.35.

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share, which is vital for long-term success.

Not available.

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

Management Promises & Guidance

Focus on increasing customer adoption of their cardiac monitoring solutions.
Commitment to enhancing product offerings through technological advancements.
Plans to improve operational efficiency to drive down costs.

Expectations

Wall Street Expectations

Bull Case

If iRhythm can demonstrate strong revenue growth and continued improvement in EPS, it may signal a recovery and increased investor confidence in the company's future.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of stagnation in customer adoption, it could lead to a negative reaction from the market.

Key Metrics to Watch

EPS (Earnings Per Share)

Expected to be around -$0.35.

EPS is a key indicator of a company's profitability and financial health, which investors closely monitor.

Revenue Growth

Not available.

Revenue growth reflects the company's ability to expand its business and capture market share, which is vital for long-term success.

Customer Adoption Rate

Not available.

Understanding how many healthcare providers are adopting iRhythm's solutions can indicate future revenue potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current customer adoption rate for iRhythm's cardiac monitoring solutions?

This metric will be crucial in assessing the company's growth potential and market acceptance of its products.

How does management plan to address operational efficiencies moving forward?

Insights into cost management strategies will help investors understand the company's path to profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for iRhythm's customer adoption rates to accelerate, especially given recent trends in telehealth and remote monitoring.

Supporting Evidence

The company has consistently beaten EPS estimates in recent quarters, indicating stronger-than-expected performance.

Options pricing suggests a higher expected move than historical averages, indicating market anticipation of significant news.

Management's commitment to improving operational efficiency could lead to better-than-expected margins.

Key Risk

If customer adoption rates exceed expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether iRhythm can sustain its recent positive momentum or if it will face ongoing challenges.

Bull Confirmed If

Demonstrating an EPS of -$0.30 or better would confirm the bull case.

Bear Confirmed If

An EPS worse than -$0.50 would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a potential move of about 3.3%, indicating that investors expect some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests a potential stock increase of around 1.17%, confirming a positive outlook.

In-Line / Cautious

A cautious in-line result may lead to muted reactions, reflecting uncertainty in future growth.

Miss

If the company misses expectations, history suggests a minimal reaction, but any significant miss could lead to a downward movement.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on customer adoption rates for cardiac monitoring solutions.
2Details on operational efficiency improvements and cost management strategies.
3Any commentary on competitive landscape and market positioning.
4Insights into product development and technological advancements.
5Management's outlook on future revenue growth and market trends.